4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta
4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta
4. Hrvatski kongres kliniËke citologije 4th Croatian Congress ... - Penta
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>4.</strong> <strong>Hrvatski</strong> <strong>kongres</strong> <strong>kliniËke</strong> <strong>citologije</strong> / 1. <strong>Hrvatski</strong> simpozij analitiËke <strong>citologije</strong> / 2. <strong>Hrvatski</strong> simpozij citotehnologije<br />
RARE TUMORS OF THE BREAST- CASES REPORTS<br />
Staklenac B1 , Lončar B1 , Pauzar B1 , Dmitrović B2 1 Clinical Hospital Osijek, Department of Clinical Cytology, Osijek, Croatia<br />
106<br />
Klinička citologija - Usmena predavanja<br />
2 Clinical Hospital Osijek, Department of Pathology and Forensic Medicine, Osijek, Croatia<br />
Introduction. FNAB and cytomorphology are standard diagnostic tools for breast tumors.<br />
The aim of this study was to demonstrate FNAC of rare breast tumors correlated with<br />
pathological and immunohistological findings. Material and methods. FNAB was performed<br />
with or without ultrasound using 22 gauge needle attached to 10 ml syringe. Material<br />
was spread to glass. Air dried smears were stained according to May-Grunwald-<br />
Giemsa method. We reported some rare tumors presented as a primary breast lumps<br />
(malignant epithelioid schwannoma, carcinoma apocrineum, malignant phyllodes tumor,<br />
carcinoma neuroendoccrineum and carcinoma planocellulare invasivum). Another<br />
two breast tumors had already established pathohistological diagnoses. The first one<br />
was Lymphoma non Hodgkin- Burkitt type (of uterus, adnexsis, cervix, omentum and<br />
appendix), and second one was CLL. Conclusion. FNAB is very useful method for distinguish<br />
rare, benign and malignant breast tumors.<br />
staklenac.blazenka@kbo.hr